The tentative price is similar to Pfizer’s projected cost of its COVID-19 vaccine: In October, a company spokesperson said it was considering listing its COVID-19 shot to be between $110 and $130 per dose.
“I would think this type of pricing is consistent with the value” of the vaccine, Moderna CEO Stéphane Bancel told the Journal.
Pfizer got some flack for valuing its COVID-19 vaccine to cost more than $100, but Georges Benjamin, MD, executive director of the American Public Health Association, told Becker’s in December the preliminary cost range is “a negotiation strategy.”
“Going from $0 to $100 for a vaccine [is] probably not going to happen,” Dr. Benjamin said of the Pfizer vaccine entering the public market.”
COVID-19 vaccines are expected to soon join the U.S. marketplace as the Biden administration plans to end the pandemic’s public health emergency this spring.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
